Skip to content
HUB Organoids
services
model and assay development
drug development services
technology
company
about us
events
latest news
careers
resources
license program
contact
Patient-derived organoids as a model for treatment diagnosis in Cystic Fibrosis – combinatory treatment with read-through agent, correctors and potentiator on rare mutations
X
Have any questions?